The goal of this clinical study is to determine the effectiveness of restoring muscle strength in the management of motor inhibition when complemented by the ALLYANE process (neuro-motor reprogramming) compared to a standard management approach. The main questions it aims to answer are: * Does the ALLYANE process lead to greater muscle strength gains compared to standard care? * Is there a functional benefit when standard management is complemented by the ALLYANE process? The investigators will compare the group receiving standard care complemented by ALLYANE to a group receiving only standard care to evaluate if the ALLYANE process provides additional effects. Participants will: * Undergo assessments of muscle strength. * Receive either standard management or standard management with ALLYANE. * Complete functional evaluations before and after treatment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Muscle activity
Timeframe: Before and 3 weeks after conventional therapy